Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Clift

Showing results (201-210 of 213) with videos related to

Pageof 22
Sort By:
Blood|February 1, 1982
Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patientsR Storb, K C Doney, E D Thomas, et al.
Blood|December 1, 1976
Aplastic anemia treated by allogeneic bone marrow transplantation: a report on 49 new cases from SeattleR Storb, E D Thomas, P L Weiden, et al.
Annals of Internal Medicine|April 1, 1983
Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblingsR Storb, R L Prentice, K M Sullivan, et al.
Blood|April 1, 1977
One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantationE D Thomas, C D Buckner, M Banaji, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myelomaW I Bensinger, S D Rowley, T Demirer, et al.
Blood|May 15, 1997
Long-term follow-up of allogeneic marrow transplants in patients with aplastic anemia conditioned by cyclophosphamide combined with antithymocyte globulinR Storb, W Leisenring, C Anasetti, et al.
Blood|September 1, 1971
Allogeneic marrow grafting for hematologic malignancy using HL-A matched donor-recipient sibling pairsE D Thomas, C D Buckner, R H Rudolph, et al.
Oncology (Williston Park, N.Y.)|February 24, 2001
NCCN Practice Guidelines for Chronic Myelogenous LeukemiaE Berman, R A Clift, E A Copelan, et al.
Bone Marrow Transplantation|June 1, 1996
Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant diseaseK S Schiffman, W I Bensinger, F R Appelbaum, et al.
Annals of the New York Academy of Sciences|July 21, 1998
Unrelated and HLA-nonidentical related donor marrow transplantation for thalassemia and leukemia. A combined report from the Seattle Marrow Transplant Team and the International Bone Marrow Transplant RegistryK M Sullivan, C Anasetti, M Horowitz, et al.
Pageof 22

Showing results (201-210 of 213) with videos related to

Sort By:
Pageof 22
Blood|February 1, 1982
Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patientsR Storb, K C Doney, E D Thomas, et al.
Blood|December 1, 1976
Aplastic anemia treated by allogeneic bone marrow transplantation: a report on 49 new cases from SeattleR Storb, E D Thomas, P L Weiden, et al.
Annals of Internal Medicine|April 1, 1983
Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblingsR Storb, R L Prentice, K M Sullivan, et al.
Blood|April 1, 1977
One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantationE D Thomas, C D Buckner, M Banaji, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myelomaW I Bensinger, S D Rowley, T Demirer, et al.
Blood|May 15, 1997
Long-term follow-up of allogeneic marrow transplants in patients with aplastic anemia conditioned by cyclophosphamide combined with antithymocyte globulinR Storb, W Leisenring, C Anasetti, et al.
Blood|September 1, 1971
Allogeneic marrow grafting for hematologic malignancy using HL-A matched donor-recipient sibling pairsE D Thomas, C D Buckner, R H Rudolph, et al.
Oncology (Williston Park, N.Y.)|February 24, 2001
NCCN Practice Guidelines for Chronic Myelogenous LeukemiaE Berman, R A Clift, E A Copelan, et al.
Bone Marrow Transplantation|June 1, 1996
Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant diseaseK S Schiffman, W I Bensinger, F R Appelbaum, et al.
Annals of the New York Academy of Sciences|July 21, 1998
Unrelated and HLA-nonidentical related donor marrow transplantation for thalassemia and leukemia. A combined report from the Seattle Marrow Transplant Team and the International Bone Marrow Transplant RegistryK M Sullivan, C Anasetti, M Horowitz, et al.
Pageof 22